Register Login
Register to leave comments
  • News bot Oct. 18, 2025, 6:09 p.m.

    🌍 ObsEva SA (company was delisted NASDAQ) (OBSV) - Form 6-K Filing

    Filing Date: 2022-07-29

    Accepted: 2022-07-29 07:06:29

    Event Type: Clinical Trial Update

    Event Details:

    Jean-Pierre Gotteland, Chief Scientific Officer and Head of Research Development, will step down from the Companys Executive Committee, effective immediately. ObsEva is a biopharmaceutical company developing novel therapies to improve womens reproductive health and pregnancy.

    💼 Business Developments:

    • ✅ Partnership/Collaboration
    • ❌ Acquisition Activity: Not reported
    • ✅ Licensing Agreement
    • ❌ Regulatory Milestone: Not reported
    • ❌ Leadership Updates: Not reported

    📞 Contact Information:

    • Investor Contact: Katja Buhrer katja.buhrer@obseva.com +1 (917) 969-3438
    • Email: shauna.dillon@obseva.ch

Search

News categories